Amarin Corp Plc (AMRN)

[couldbebetter]

Ggwpq, Good drugs do not sell themselves. Hopefully, KM has the
experience to insure a successful launch of Vazepa in Europe and
perhaps even get the company acquired in due time by BP. Thero
was a CPA with no BP experience behind him...He was the wrong guy
for the job. KM is a seasoned BP executive with experience in
launching new drugs in Europe. Europe is where the big money will
be made. Except, if a BP acquires AMRN they have the capability to
deliver much greater revenues and optimize uptake much faster.

Imagine if a BP acquired AMRN and decided that a generic version
would be the way to go in the US market. Could they rebrand or
relaunch the drug in some way to achieve greater sales in the US?
I don't know, but BP may have a solution; Thero's strategy failed.